| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d1435fdb85d367c0522188ff4ad3c04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b58bcfcda940f22c3ad85f929cb17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e06084bd629b99de637f7569680d5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7c3a4bcf15564323347848ddffee85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38d70a8361eeadb19817e246acc196f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1381b43602f0054062c4d6a9d713872b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f65dbe9c7c9dcc4f76d675e6e0a6e66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df790e54419f49add27af080b03e7be0 |
| publicationDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101731078-B1 |
| titleOfInvention |
Bilayer tablets comprising bepotastine or its salt |
| abstract |
The present invention relates to a process for the preparation of beatifastine-dehydrogenase inhibitors for once-a-day administration which can be applied in the field of production simply by avoiding the use of irritating polymer polyethylene oxide and also by formulating it with suitable additives, Containing double-layered tablet. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200067406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102258372-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190069954-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020175897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019088490-A1 |
| priorityDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |